Viewing StudyNCT00809965

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 9:04 PM
Last Modification Date: 2024-10-26 @ 9:59 AM
Study NCT ID: NCT00809965
Status: COMPLETED
Last Update Posted: 2014-09-17
First Post: 2008-12-16
Brief Title: An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Unstable Angina
Acute Coronary Syndrome
Myocardial Infarction
Myocardial Ischemia
Keywords:
Name View
Clopidogrel Plavix View
Rivaroxaban View
Acute Coronary Syndrome View
ACS View
Aspirin View
Thienopyridine View
Unstable Angina View
Myocardial Infarction View
Anticoagulation View